Skip to Content for News Events Menu for News Events About Us Menu Research Menu Development Menu Medicines Menu Investors Menu Media Menu Careers Menu
Banner Image

News Events

September 2009 Genentech Goes to Town 2009

In 2009, Genentech Goes to Town takes place September 14 to September 25 in South San Francisco, Vacaville, Oceanside and Hillsboro. The Genentech Goes to Town program supports our communities by providing employees with special "GenenMoney" to spend at local businesses.

September 2009 Genentech Scientists Publish Data on Hedgehog Pathway Inhibitor

Hedgehog MOA In the New England Journal of Medicine and Science, Genentech scientists Frederic de Sauvage and Jennifer Low present Phase I data on a Hedgehog Pathway Inhibitor in basal cell carcinoma and in a medulloblastoma case study.


Read the NEJM abstract on medulloblastoma.

Read the NEJM abstract on basal cell carcinoma.
Read the abstract published in Science.

Watch a video interview with Frederic de Sauvage and Jennifer Low.
View Frederic de Sauvage's researcher profile.

Watch a video of Hedgehog Pathway Inhibitor's proposed method of action.
Learn more about Hedgehog Pathway Inhibitor.

Learn more about Genentech's development pipeline.

June 2009 Arbitration Panel Decision Received in Decision-Making Disagreement Between Genentech and Biogen Idec

Genentech and our collaborator Biogen Idec disagreed over decision-making rights for certain of the next-generation anti-CD20 products under our 2003 collaboration agreement, and the disagreement was submitted to an arbitration panel, which issued a ruling in June 2009.

Read more about the arbitration panel decision.

February 2009 Nature Logo In a paper published in the February 19, 2009 issue of Nature, Genentech neuroscience scientists Marc Tessier-Lavigne and Anatoly Nikolaev, together with scientists from the Salk Institute, provide a new way of looking at Alzheimer's disease.